These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2444317)

  • 1. [Suppression of lymphocyte function in vitro with placental gamma-globulin].
    Dong YH
    Zhonghua Yi Xue Za Zhi; 1987 Jul; 67(7):385-8. PubMed ID: 2444317
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of human placental gamma globulin in blocking immune functions in vitro and in abrogating the xenogeneic, local graft-versus-host reaction.
    Zhong RK; Dong YH; Lu DP
    Chin Med J (Engl); 1989 Jul; 102(7):537-44. PubMed ID: 2483543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of non-rejection of foeto-placental allografts.
    Beer AE; Billingham RE
    Folia Biol (Praha); 1980; 26(4):225-43. PubMed ID: 6157577
    [No Abstract]   [Full Text] [Related]  

  • 4. The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin.
    Gahring LC; Weigle WO
    J Immunol; 1989 Oct; 143(7):2094-100. PubMed ID: 2476497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of immunologic unresponsiveness to human gamma-globulin: evidence for irreversible inactivation in B lymphocytes.
    Parks DE; Weigle WO
    J Immunol; 1980 Mar; 124(3):1230-6. PubMed ID: 6153675
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of clonal abortion tolerogenesis. IV. Verification of the hypothesis in living mice.
    Kay TW; Pike BL; Nossal GJ
    J Immunol; 1980 Apr; 124(4):1579-84. PubMed ID: 6154074
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of early antigen exposure through lactation on later specific antibody responses in mice.
    Komatsu T; Okao M; Miyamoto H; Chen T; Shinka S
    J Immunol; 1988 Nov; 141(9):2895-906. PubMed ID: 2459232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK; Koh MB; Lowdell MW
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G.
    Denman AM; Frenkel EP
    J Immunol; 1967 Sep; 99(3):498-507. PubMed ID: 4167593
    [No Abstract]   [Full Text] [Related]  

  • 12. The cellular basis for tolerance or immunity to bovine-gamma-globulin in mice.
    Das S; Leskowitz S
    J Immunol; 1974 Jan; 112(1):107-14. PubMed ID: 4130144
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of donor T cells in systemic graft-versus-host reaction.
    Matsubayashi Y; Kuribayashi K; Masuda T; Uchino H
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3036-8. PubMed ID: 2565066
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
    Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
    Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of alloreactive T-cell depletion using biotinylated galactose oxidase for the prevention of acute graft-versus-host diseases.
    Yabe H; Watanabe T; Kimura M; Nakane PK
    Tokai J Exp Clin Med; 1988 Dec; 13(4-5):227-38. PubMed ID: 3256939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression or enhancement of natural killing does not alter tolerance to bovine gamma globulin.
    Loeb JM; Talal N; Abensohn-Lee M; Seaman WE
    J Clin Lab Immunol; 1981 Nov; 6(3):215-20. PubMed ID: 6175754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance to human gamma-globulin in FcR gamma- and Fc gammaRII-deficient mice.
    Whitmer KJ; Romball CG; Weigle WO
    J Immunol; 1997 Jul; 159(2):644-9. PubMed ID: 9218579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of long-term transplantation tolerance, chimerism, and host-versus-graft disease: interrelationship and cellular requirements.
    DeNardin AM; Brentjens JR; Andres GA; Nakamura I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):265-6. PubMed ID: 2784894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.